Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
7.10%
GROSS MARGIN AVG 20Y
18.76%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
-100.00%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Dyne Therapeutics, Inc.
Market Cap
$2.88B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.79B
Gross Margin
58.69%
TTM Avg
59.64%
3Y Avg
63.22%
5Y Avg
64.62%
Market Cap
$3.01B
Gross Margin
91.14%
TTM Avg
90.25%
3Y Avg
87.92%
5Y Avg
58.61%
Market Cap
$3.06B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$3.09B
Gross Margin
0.00%
TTM Avg
25.88%
3Y Avg
57.90%
5Y Avg
-575.35%
Market Cap
$3.09B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
50.00%
5Y Avg
66.67%
Market Cap
$2.67B
Gross Margin
17.61%
TTM Avg
20.09%
3Y Avg
39.91%
5Y Avg
58.59%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | $2.88B | 0.00% | 0.00% | 0.00% | 0.00% |
| TransMedics Group, Inc. (TMDX)vs › | $2.79B | 58.69% | 59.64% | 63.22% | 64.62% |
| AtriCure, Inc. (ATRC)vs › | $2.78B | 76.16% | 74.55% | 74.69% | 74.35% |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.01B | 91.14% | 90.25% | 87.92% | 58.61% |
| Precigen, Inc. (PGEN)vs › | $2.73B | 37.05% | 14.17% | 26.62% | -34.97% |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.06B | 0.00% | 0.00% | 0.00% | 0.00% |
| Amylyx Pharmaceuticals, Inc. (AMLX)vs › | $3.09B | 0.00% | 25.88% | 57.90% | -575.35% |
| Denali Therapeutics Inc. (DNLI)vs › | $3.09B | 0.00% | 0.00% | 50.00% | 66.67% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.67B | 17.61% | 20.09% | 39.91% | 58.59% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.66B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2017-12-31 | -50.43% |
| 2017-09-30 | -332.42% |
| 2017-06-30 | -276.24% |
| 2017-03-31 | -332.57% |
| 2016-12-31 | 26.30% |
| 2016-09-30 | -173.86% |
| 2016-06-30 | -196.99% |
| 2016-03-31 | -224.40% |
| 2015-12-31 | -146.08% |
| 2015-09-30 | 0.64% |
| 2015-06-30 | 69.42% |
| 2015-03-31 | 40.35% |
| 2014-12-31 | 21.90% |
| 2014-09-30 | 37.07% |
| 2014-06-30 | 29.94% |
| 2014-03-31 | 27.56% |
| 2013-12-31 | -10500.00% |
| 2013-09-30 | 34.98% |
| 2013-06-30 | 15.95% |
| 2013-03-31 | 10.69% |
| 2012-12-31 | -123.40% |
| 2012-09-30 | 30.42% |
| 2012-06-30 | 76.77% |
| 2012-03-31 | 51.41% |
| 2011-12-31 | 31.93% |
| 2011-09-30 | 42.25% |
| 2011-06-30 | 30.98% |
| 2011-03-31 | 44.95% |
| 2010-12-31 | -161.86% |
| 2010-09-30 | 56.90% |
| 2010-06-30 | 90.86% |
| 2010-03-31 | 64.10% |
| 2009-12-31 | 39.46% |
| 2009-09-30 | 58.57% |
| 2009-06-30 | 39.79% |
| 2009-03-31 | 73.14% |
| 2008-12-31 | 51.19% |
| 2008-09-30 | 70.41% |
| 2008-06-30 | -141.49% |
| 2008-03-31 | 12.14% |
| 2007-12-31 | 26.10% |
| 2007-09-30 | 37.95% |
| 2007-06-30 | 41.71% |
